What is Time in Range?
Time in Range is the amount of time spent within a healthy glucose range of 70 - 180 mg/dL. Spending more time in range throughout the day makes sure you are spending less time high or low.
Why Does Time in Range Matter?
More time in range means fewer highs & lows – and is correlated with better quality of life.1,2 More time in range means more time feeling healthy and confident about your diabetes management.3
Technology Can Help
Insulin Pump Therapy and Continuous Glucose Monitoring (CGM) can help you keep your glucose levels in range so you can feel better. And when you feel better, you can focus more on the rest of your life. See below for more details.
People can benefit from an insulin pump who want to:4
An insulin pump gives you insulin in a way that matches your needs better than shots or pens can. It’s about the size of a small cell phone and you can wear it discreetly on your belt, in your pocket or under your clothes.
Continuous glucose monitoring (CGM) lets you see your glucose numbers anytime, anywhere so you can be more proactive about your diabetes. A small sensor measures glucose levels from the fluid under your skin and a coin-sized transmitter sends those readings to a smartphone or insulin pump. Using a glucose monitor may allow glucose readings as often as every 5 minutes, allowing you to fingerstick less often. CGM can be used with or without an insulin pump.*
There is a range of options when it comes to CGM products. Some of them can predict future high and low sensor glucose events anywhere from 10 minutes to up to 60 minutes in advance. And there are CGM options that can also provide input on how activities, food and insulin may be impacting your levels.**
CGM is especially beneficial for people who:5
* Only Guardian™ Connect Smart CGM and iPro2™ Professional CGM can be used without an insulin pump.
** Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance and provides access to additional algorithms and insights that can inform users of clinically relevant glucose patterns.
*** The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained using a home blood glucose meter and not on values provided by the system.
1. Vanstone, M, Rewegan, A, Brundisini, F, et al. Patient perspectives on quality of life with uncontrolled type 1 diabetes mellitus: A systematic review and qualitative meta-synthesis. Ont Health Technol Ser. 2015; 15(17):1-29
2. Ayano-Takahara, S, Ikeda, K, Fujimoto, S, Hamasaki, A, et al. Glycemic variability is associated with quality of life and treatment satisfaction in patients with type 1 diabetes. Diabetes Care. 2015 Jan; 38(1): e1-e
3. Bergenstal R, Garg S, Weinzimer S, et al. Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. JAMA. 2016;316(13):1407–1408
4. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. Endocr Pract. 2007; 13(suppl 1):1-68
5. Grunberger G, Bailey TS, Cohen AJ, et al; and AACE Insulin Pump Management Task Force. Statement by the American Association of Clinical Endocrinologists Consensus Panel on insulin pump management. Endocr Pract. 2010;16(4):746-762.
IMPORTANT SAFETY INFORMATION
Medtronic Diabetes insulin infusion pumps, continuous glucose monitoring systems and associated components are limited to sale by or on the order of a physician and should only be used under the direction of a healthcare professional familiar with the risks associated with the use of these systems. Successful operation of the insulin infusion pumps and/or continuous glucose monitoring systems requires adequate vision and hearing to recognize alerts and alarms.
Medtronic Diabetes Insulin Infusion Pumps
Insulin pump therapy is not recommended for individuals who are unable or unwilling to perform a minimum of four blood glucose tests per day. Insulin pumps use rapid-acting insulin. If your insulin delivery is interrupted for any reason, you must be prepared to replace the missed insulin immediately.
Medtronic Diabetes Continuous Glucose Monitoring (CGM) Systems
The information provided by CGM systems is intended to supplement, not replace, blood glucose information obtained using a home glucose meter. A confirmatory finger stick is required prior to treatment. Insertion of a glucose sensor may cause bleeding or irritation at the insertion site. Consult a physician immediately if you experience significant pain or if you suspect that the site is infected. Please visit www.medtronicdiabetes.com/about/safety.html for additional details.